Gilead Sciences (GILD) Price to FCF (2009 - 2026)
Gilead Sciences' (GILD) quarterly Price to FCF came in at 45.67 in Q2 2026, down 76.12% on a YoY basis from 191.25 in Q2 2025, and down 35.96% quarter-over-quarter from 71.32 in Q1 2026.
Analysis
Gilead Sciences (GILD) Price to FCF (2009 - 2026) Analysis & Trends
Gilead Sciences (GILD) has reported Price to FCF for 18 consecutive years, with 45.67 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Price to FCF fell 76.12% year-over-year to 45.67; the trailing twelve-month figure through Jun 2026 stood at 12.11 (down 17.58% YoY), and the FY2025 full-year result was 16.11, up 44.23% from the prior year.
- Price to FCF slipped to 45.67 in Q2 2026 per GILD's latest filing, from 71.32 in the prior quarter.
- Across five years, Price to FCF topped out at 191.25 in Q2 2025 and bottomed at 25.06 in Q3 2024.
- Historically, Price to FCF has averaged 57.76 across 5 years, with a median of 46.78 in 2022.
- The sharpest annual moves came in 2025 and 2026: Price to FCF soared 167.34% in 2025, then slumped 76.12% in 2026.
- Over 5 years, Price to FCF stood at 44.87 in 2022, then gained by 15.13% to 51.66 in 2023, then declined by 21.22% to 40.7 in 2024, then rose by 19.88% to 48.79 in 2025, then fell by 6.39% to 45.67 in 2026.
- According to Business Quant data, Price to FCF over the past three periods registered 45.67, 71.32, and 48.79 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | BioNTech SE | 26.24 Bn | 12.58 Bn | 10.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45.67 |
| Mar 31, 2026 | 71.32 |
| Dec 31, 2025 | 48.79 |
| Sep 30, 2025 | 34.80 |
| Jun 30, 2025 | 191.25 |
| Mar 31, 2025 | 84.39 |
| Dec 31, 2024 | 40.70 |
| Sep 30, 2024 | 25.06 |
| Jun 30, 2024 | 71.54 |
| Mar 31, 2024 | 43.17 |
| Dec 31, 2023 | 51.66 |
| Sep 30, 2023 | 57.23 |
| Jun 30, 2023 | 43.70 |
| Mar 31, 2023 | 63.33 |
| Dec 31, 2022 | 44.87 |
| Sep 30, 2022 | 28.59 |
| Jun 30, 2022 | 46.72 |
| Mar 31, 2022 | 46.84 |
| Dec 31, 2021 | 29.86 |
| Sep 30, 2021 | 28.15 |